How Nigeria can Regain Vaccine Self-Reliance

Three vaccines have been licensed for use in controlling the COVID-19 pandemic – Oxford-AstraZeneca, Moderna and Pfizer. Nigeria is currently expecting 100,000 doses of the Pfizer/BioNTech vaccine by the end of January through COVAX, the global alliance to ensure equitable access to vaccines for everybody. Because each person needs two doses of the vaccine spaced … Continue reading How Nigeria can Regain Vaccine Self-Reliance